{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:55:57Z","timestamp":1776329757608,"version":"3.50.1"},"reference-count":42,"publisher":"Baskent University","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.6002\/ect.2022.0359","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T02:58:53Z","timestamp":1675133933000},"page":"1105-1113","source":"Crossref","is-referenced-by-count":0,"title":["Induction Versus Maintenance Immunosuppression After Intestinal Transplant: Determining Which Treatment Most Impacts Long-Term Patient And Graft Survival"],"prefix":"10.6002","volume":"20","author":[{"given":"Mar\u00eda Virginia","family":"Gentilini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Perez-Illidge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00e9stor","family":"Pedraza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio Iv\u00e1n","family":"Nemirovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Florencia","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Ramisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor","family":"Solar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn","family":"Rumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Rumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel E.","family":"Gondolesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4021","reference":[{"key":"ref0","unstructured":"References"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"1. Gondolesi GE, Doeyo M, Solar-Muniz H. A detailed analysis of the current status of intestinal transplantation in Latin America. Curr Opin Organ Transplant. 2020;25(2):189-195. doi:10.1097\/MOT.0000000000000737","DOI":"10.1097\/MOT.0000000000000737"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"2. Kesseli S, Sudan D. Small bowel transplantation. Surg Clin North Am. 2019;99(1):103-116. doi:10.1016\/j.suc.2018.09.008","DOI":"10.1016\/j.suc.2018.09.008"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"3. Todo S, Reyes J, Furukawa H, et al. Outcome analysis of 71 clinical intestinal transplantations. Ann Surg. 1995;222(3):270-280; discussion 280-272. doi:10.1097\/00000658-199509000-00006","DOI":"10.1097\/00000658-199509000-00006"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"4. Abu-Elmagd KM, Costa G, Bond GJ, et al. Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann Surg. 2009;250(4):567-581. doi:10.1097\/SLA.0b013e3181b67725","DOI":"10.1097\/SLA.0b013e3181b67725"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"5. Berger M, Zeevi A, Farmer DG, Abu-Elmagd KM. Immunologic challenges in small bowel transplantation. Am J Transplant. 2012;12 Suppl 4:S2-8. doi:10.1111\/j.1600-6143.2012.04332.x","DOI":"10.1111\/j.1600-6143.2012.04332.x"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"6. Vianna R, Farag A, Gaynor JJ, et al. Association of more intensive induction with less acute rejection following intestinal transplantation: results of 445 consecutive cases from a single center. Transplantation. 2020;104(10):2166-2178. doi:10.1097\/TP.0000000000003074","DOI":"10.1097\/TP.0000000000003074"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"7. Ramisch D, Rumbo C, Echevarria C, et al. Long-term outcomes of intestinal and multivisceral transplantation at a single center in Argentina. Transplant Proc. 2016;48(2):457-462. doi:10.1016\/j.transproceed.2015.12.066","DOI":"10.1016\/j.transproceed.2015.12.066"},{"key":"ref8","unstructured":"8. Lopez Santamaria M, Hernandez Oliveros F. [Indications, techniques, and outcomes of small bowel transplant]. Nutr Hosp. 2007;22 Suppl 2:113-123."},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"9. Vianna RM, Mangus RS, Fridell JA, Weigman S, Kazimi M, Tector J. Induction immunosuppression with thymoglobulin and rituximab in intestinal and multivisceral transplantation. Transplantation. 2008;85(9):1290-1293. doi:10.1097\/TP.0b013e31816dd450","DOI":"10.1097\/TP.0b013e31816dd450"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"10. Gondolesi GE. Induction in intestinal transplantation. Transplantation. 2020;104(10):1999-2000. doi:10.1097\/TP.0000000000003081","DOI":"10.1097\/TP.0000000000003081"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"11. Raghu VK, Vetterly CG, Horslen SP. Immunosuppression regimens for intestinal transplantation in children. Paediatr Drugs. 2022;24(4):365-376. doi:10.1007\/s40272-022-00512-3","DOI":"10.1007\/s40272-022-00512-3"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"12. Lerut JP, Gondolesi GE. Immunosuppression in liver and intestinal transplantation. Best Pract Res Clin Gastroenterol. 2021;54-55:101767. doi:10.1016\/j.bpg.2021.101767","DOI":"10.1016\/j.bpg.2021.101767"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"13. Tsaroucha AK, Zucker K, Esquenazi V, de Faria L, Miller J, Tzakis AG. Levels of mycophenolic acid and its glucuronide derivative in the plasma of liver, small bowel and kidney transplant patients receiving tacrolimus and Cellcept combination therapy. Transpl Immunol. 2000;8(2):143-146. doi:10.1016\/s0966-3274(00)00012-5","DOI":"10.1016\/S0966-3274(00)00012-5"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"14. Merola J, Shamim A, Weiner J. Update on immunosuppressive strategies in intestinal transplantation. Curr Opin Organ Transplant. 2022;27(2):119-125. doi:10.1097\/MOT.0000000000000958","DOI":"10.1097\/MOT.0000000000000958"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"15. Timpone JG, Jr., Girlanda R, Rudolph L, Fishbein TM. Infections in intestinal and multivisceral transplant recipients. Infect Dis Clin North Am. 2013;27(2):359-377. doi:10.1016\/j.idc.2013.02.012","DOI":"10.1016\/j.idc.2013.02.012"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"16. Trevizol AP, David AI, Dias ER, Mantovani D, Pecora R, D'Albuquerque LA. Intestinal and multivisceral transplantation immunosuppression protocols--literature review. Transplant Proc. 2012;44(8):2445-2448. doi:10.1016\/j.transproceed.2012.07.016","DOI":"10.1016\/j.transproceed.2012.07.016"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"17. Nikoupour H, Arasteh P, Shamsaeefar A, et al. Surgical management of intestinal failure; initial experiences from an intestinal failure, rehabilitation and transplant unit in Iran. Arch Iran Med. 2021;24(4):289-295. doi:10.34172\/aim.2021.40","DOI":"10.34172\/aim.2021.40"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"18. Solar H, Ortega M, Gondolesi GE. Quality of life after intestinal transplantation. Curr Opin Organ Transplant. 2021;26(2):200-206. doi:10.1097\/MOT.0000000000000852","DOI":"10.1097\/MOT.0000000000000852"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"19. Gondolesi G, Blondeau B, Maurette R, et al. Pretransplant immunomodulation of highly sensitized small bowel transplant candidates with intravenous immune globulin. Transplantation. 2006;81(12):1743-1746. doi:10.1097\/01.tp.0000226078.94635.76","DOI":"10.1097\/01.tp.0000226078.94635.76"},{"issue":"10","key":"ref20","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1001\/jama.1989.03420100085029","article-title":"Transplantation of multiple abdominal viscera","volume":"261","author":"Starzl","year":"1989","unstructured":"20. Starzl TE, Rowe MI, Todo S, et al. Transplantation of multiple abdominal viscera. JAMA. 1989;261(10):1449-1457.","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"21. Ruiz P. How can pathologists help to diagnose late complications in small bowel and multivisceral transplantation? Curr Opin Organ Transplant. 2012;17(3):273-279. doi:10.1097\/MOT.0b013e3283534eb0","DOI":"10.1097\/MOT.0b013e3283534eb0"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"22. Ruiz P, Bagni A, Brown R, et al. Histological criteria for the identification of acute cellular rejection in human small bowel allografts: results of the pathology workshop at the VIII International Small Bowel Transplant Symposium. Transplant Proc. 2004;36(2):335-337. doi:10.1016\/j.transproceed.2004.01.079","DOI":"10.1016\/j.transproceed.2004.01.079"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"23. Vanrenterghem Y, van Hooff JP, Squifflet JP, et al. Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial. Am J Transplant. 2005;5(1):87-95. doi:10.1111\/j.1600-6143.2004.00638.x","DOI":"10.1111\/j.1600-6143.2004.00638.x"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"24. Mazariegos GV, Abu-Elmagd K, Jaffe R, et al. Graft versus host disease in intestinal transplantation. Am J Transplant. 2004;4(9):1459-1465. doi:10.1111\/j.1600-6143.2004.00524.x","DOI":"10.1111\/j.1600-6143.2004.00524.x"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"25. Platz KP, Braun F, Fandrich F, Kremer B, Mueller AR. IL-2 antagonists: the European perspective. Transplant Proc. 2005;37(4):1783-1784. doi:10.1016\/j.transproceed.2005.03.131","DOI":"10.1016\/j.transproceed.2005.03.131"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"26. Farmer DG, McDiarmid SV, Edelstein S, et al. Induction therapy with interleukin-2 receptor antagonist after intestinal transplantation is associated with reduced acute cellular rejection and improved renal function. Transplant Proc. 2004;36(2):331-332. doi:10.1016\/j.transproceed.2004.01.099","DOI":"10.1016\/j.transproceed.2004.01.099"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"27. Vitko S, Klinger M, Salmela K, et al. Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus\/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study. Transplantation. 2005;80(12):1734-1741. doi:10.1097\/01.tp.0000188300.26762.74","DOI":"10.1097\/01.tp.0000188300.26762.74"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"28. Peddi VR, Bryant M, Roy-Chaudhury P, Woodle ES, First MR. Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients. Transplantation. 2002;73(9):1514-1518. doi:10.1097\/00007890-200205150-00025","DOI":"10.1097\/00007890-200205150-00025"},{"key":"ref29","unstructured":"29. Franco A, Cotilla E, Roca S, et al. [Clinical course of high and low immunological risk renal transplant receptors subjected to different immunosuppressive treatments]. Nefrologia. 2009;29(6):557-561. doi:10.3265\/Nefrologia.2009.29.6.5486.en.full"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"30. Nakai K, Mineishi S, Kami M, et al. Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution. Transplantation. 2003;75(12):2135-2143. doi:10.1097\/01.TP.0000066453.32263.F7","DOI":"10.1097\/01.TP.0000066453.32263.F7"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"31. Abu-Elmagd KM, Costa G, Bond GJ, et al. Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance. Transpl Int. 2009;22(1):96-109. doi:10.1111\/j.1432-2277.2008.00785.x","DOI":"10.1111\/j.1432-2277.2008.00785.x"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"32. Meyer D, Otto C, Rummel C, et al. \"Tolerogenic effect\" of the liver for a small bowel allograft. Transpl Int. 2000;13 Suppl 1:S123-126. doi:10.1007\/s001470050296","DOI":"10.1007\/s001470050296"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"33. Zhong R, He G, Sakai Y, et al. Combined small bowel and liver transplantation in the rat: possible role of the liver in preventing intestinal allograft rejection. Transplantation. 1991;52(3):550-552. doi:10.1097\/00007890-199109000-00033","DOI":"10.1097\/00007890-199109000-00033"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"34. McCaughan GW, Bowen DG, Bertolino PJ. Induction phase of spontaneous liver transplant tolerance. Front Immunol. 2020;11:1908. doi:10.3389\/fimmu.2020.01908","DOI":"10.3389\/fimmu.2020.01908"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"35. Selvaggi G, Gaynor JJ, Moon J, et al. Analysis of acute cellular rejection episodes in recipients of primary intestinal transplantation: a single center, 11-year experience. Am J Transplant. 2007;7(5):1249-1257. doi:10.1111\/j.1600-6143.2007.01755.x","DOI":"10.1111\/j.1600-6143.2007.01755.x"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"36. Grant D, Abu-Elmagd K, Mazariegos G, et al. Intestinal transplant registry report: global activity and trends. Am J Transplant. 2015;15(1):210-219. doi:10.1111\/ajt.12979","DOI":"10.1111\/ajt.12979"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"37. Abu-Elmagd KM, Wu G, Costa G, et al. Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver. Am J Transplant. 2012;12(11):3047-3060. doi:10.1111\/j.1600-6143.2012.04237.x","DOI":"10.1111\/j.1600-6143.2012.04237.x"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"38. Kudo H, Wada M, Sasaki H, et al. Intestinal transplantation at a single institution in Japan. Transplant Proc. 2021;53(6):2040-2045. doi:10.1016\/j.transproceed.2021.06.021","DOI":"10.1016\/j.transproceed.2021.06.021"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"39. Ueno T, Teraoka N, Takasu S, et al. Suppressive effect of pioglitazone, a PPAR gamma ligand, on azoxymethane-induced colon aberrant crypt foci in KK-Ay mice. Asian Pac J Cancer Prev. 2012;13(8):4067-4073. doi:10.7314\/apjcp.2012.13.8.4067","DOI":"10.7314\/APJCP.2012.13.8.4067"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"40. Iyer KR, Srinath C, Horslen S, et al. Late graft loss and long-term outcome after isolated intestinal transplantation in children. J Pediatr Surg. 2002;37(2):151-154. doi:10.1053\/jpsu.2002.30240","DOI":"10.1053\/jpsu.2002.30240"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"41. Fishbein TM, Kaufman SS, Florman SS, et al. Isolated intestinal transplantation: proof of clinical efficacy. Transplantation. 2003;76(4):636-640. doi:10.1097\/01.TP.0000083042.03188.6C","DOI":"10.1097\/01.TP.0000083042.03188.6C"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T03:28:24Z","timestamp":1675135704000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/archive\/2022\/20\/12\/0\/1105\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2022.0359","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}